Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01749605 · ClinicalTrials.gov registry record · Phase 4
A Pilot Comparison of Short-course Nitrofurantoin in Females With Uncomplicated Bacterial Cystitis in the Emergency Department
A Phase 4 study, sponsored by University of Iowa.
- Completed
- Registry status
- Phase 4
- Development phase
- 35
- Enrollment target
NCT01749605 is a Phase 4 study that has completed, run by University of Iowa. The registered enrollment target is 35 participants.
The verdict
NCT01749605, a Phase 4 study, has completed, sponsored by University of Iowa.
- COMPLETED
- Registry status
- Phase 4
- Development phase
- 35 participants
- Enrollment target
Study Summary
Pilot study to compare the efficacy and safety of 3-day, twice-daily regimens of nitrofurantoin and ciprofloxacin in emergency department (ED) patients presenting with UBC.
Interventions
- DRUG Nitrofurantoin monohydrate/macrocrystals 100 mg BID x 3 days
- DRUG ciprofloxacin 250 mg BID x 3 days
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 35 participants |
| Start Date | 2010-10 |
| Est. Completion | 2012-01 |
| Phase | Phase 4 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01749605
The ClinicalTrials.gov registry entry for NCT01749605 describes a study currently listed as completed, categorized as Phase 4. The registered enrollment target is 35 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of Iowa, which has 228 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Nitrofurantoin monohydrate/macrocrystals 100 mg BID x 3 days is the first listed.
NCT01749605 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT01749605 about?
NCT01749605 is a clinical study titled "A Pilot Comparison of Short-course Nitrofurantoin in Females With Uncomplicated Bacterial Cystitis in the Emergency Department". Pilot study to compare the efficacy and safety of 3-day, twice-daily regimens of nitrofurantoin and ciprofloxacin in emergency department (ED) patients presenting with UBC.
What is the current status of trial NCT01749605?
This trial is currently completed. It is a Phase 4 study. The enrollment target is 35 participants. The study started on 2010-10. Estimated completion is 2012-01.
What interventions are being tested in trial NCT01749605?
The interventions under investigation include: Nitrofurantoin monohydrate/macrocrystals 100 mg BID x 3 days (DRUG), ciprofloxacin 250 mg BID x 3 days (DRUG).
Who is sponsoring clinical trial NCT01749605?
This trial is sponsored by University of Iowa, which has 228 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.